Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,396
+$1,958 QoQ
Shares Held
7
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4,586
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Redwood Park Advisors LLC holds $860,163 across 8 Drug Manufacturers - General names. LLY ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
2,110 | $271,135 | |
| 2 | AMGN |
Amgen Inc
|
702 | $254,208 | |
| 3 | JNJ |
Johnson & Johnson
|
915 | $232,382 | |
| 4 | ABBV |
AbbVie Inc.
|
222 | $55,864 | |
| 5 | PFE |
Pfizer Inc
|
986 | $23,742 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
67 | $8,464 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
7 | $8,396 | |
| 8 | SNY |
Sanofi
|
140 | $5,972 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,396 | 7 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,438 | 7 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $7,522 | 7 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,341 | 7 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,456 | 7 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $9,085 | 11 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,492 | 11 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||